Healthcare Services

Chronic Pancreatitis Market Forecast to 2030: Trends and Insights

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Chronic Pancreatitis (CP) Market From 2026 To 2030?

The chronic pancreatitis (cp) market size has shown significant growth in recent years. It is anticipated to increase from $5.23 billion in 2025 to $5.56 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.4%. Historically, this expansion has been influenced by factors such as enhanced availability of diagnostic imaging, heightened awareness of pancreatic disorders, broader adoption of pain management therapies, the expansion of gastroenterology services, and improved supportive care options.

The market for chronic pancreatitis (CP) is projected to experience robust expansion over the coming years. This market is anticipated to reach $7.05 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this growth during the projection period include the increasing creation of advanced enzyme formulations, a heightened emphasis on early intervention, the broadening of outpatient treatment approaches, the growing incorporation of nutrition-centric therapies, and rising investment in research related to pancreatic diseases. Key trends anticipated during the forecast encompass the increased application of enzyme replacement therapies, the growing embrace of minimally invasive endoscopic procedures, an elevated focus on nutritional care, the broadening of personalized treatment strategies, and a stronger emphasis on prompt diagnosis.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/chronic-pancreatitis-cp-global-market-report

Which Important Drivers Are Guiding The Chronic Pancreatitis (CP) Market Growth?

A rise in alcohol intake is anticipated to fuel the expansion of the chronic pancreatitis market moving forward. Alcohol consumption involves drinking beverages containing ethanol, typically for recreational, social, or cultural reasons, though excessive consumption can lead to dependence or health risks. This escalation in alcohol consumption is influenced by factors such as greater social acceptance, urbanization, evolving lifestyles, and strategies for managing stress, particularly among younger demographics. The intake of alcohol triggers chronic pancreatitis by initiating inflammation and damage to pancreatic cells, resulting in fibrosis, ductal blockages, and long-term organ dysfunction due to toxic metabolic byproducts. For example, in 2025, a 2023 survey by the Priory Group, a UK-based provider of mental health, addiction, and specialist education services, revealed that 25% of UK individuals aged 18–24 currently abstain from alcohol completely, indicating a notable trend towards sobriety among the younger generation. Consequently, the rising consumption of alcohol is propelling the growth of the chronic pancreatitis market.

How Are Different Segments Classified In The Chronic Pancreatitis (CP) Market Segment Analysis?

The chronic pancreatitis (cp) market covered in this report is segmented –

1) By Treatment: Analgesic, Artificial Digestive Enzyme, Protein Supplements, Other Treatments

2) By Diagnosis: Computed Tomography (CT) Scan, Magnetic Resonance Cholangiopancreatography, Ultrasound Sonography, Other Diagnosis

3) By Route Of Administration: Oral, Parenteral

4) By End User: Hospitals, Homecare, Other End Users

Subsegments:

1) By Analgesic: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids

2) By Artificial Digestive Enzyme: Pancrelipase, Pancreatin

3) By Protein Supplements: Branched-Chain Amino Acids (BCAA), Whey Protein

4) By Other Treatments: Endoscopic Treatment, Surgery

What Trends Are Influencing The Evolution Of The Chronic Pancreatitis (CP) Market?

Leading firms within the chronic pancreatitis market are concentrating on creating technological innovations, particularly enzyme replacement therapy, to tackle exocrine pancreatic insufficiency (EPI) linked with chronic pancreatitis. This therapy entails the ingestion of oral pancreatic enzymes, which assists digestion for individuals experiencing inadequate pancreatic function. An example of this is seen in July 2023, when First Wave BioPharma Inc, a US-based clinical-stage biopharmaceutical company, disclosed findings from its Phase 2 SPAN clinical trial. This trial examined an improved enteric microgranule delivery formulation of adrulipase, intended for treating exocrine pancreatic insufficiency (EPI) in patients suffering from both cystic fibrosis (CF) and chronic pancreatitis. Adrulipase itself is a recombinant lipase enzyme, originating from the Yarrowia lipolytica yeast, and is administered as an oral, non-systemic biologic capsule. Its purpose is to break down fat molecules within the digestive tract of EPI patients, facilitating their absorption as nutrients.

Who Are The Companies Driving Activity In The Chronic Pancreatitis (CP) Market?

Major companies operating in the chronic pancreatitis (cp) market are Pfizer, Johnson & Johnson, Merck & Co Inc, AbbVie Inc, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Baxter, CSL Behring, Octapharma AG, Dr. Reddy’s Laboratories, Nestle Health Science, Cerata Pharmaceuticals, Unichem Laboratories Ltd, LGM Pharma, Aptalis Pharmaceutical Technologies, Digestive Care Inc, Akron Biotech

Get The Full Chronic Pancreatitis (CP) Market Report:

https://www.thebusinessresearchcompany.com/report/chronic-pancreatitis-cp-global-market-report

Which Region Represents The Largest Share Of The Chronic Pancreatitis (CP) Market?

North America was the largest region in the chronic pancreatitis (CP) market in 2025. The regions covered in the chronic pancreatitis (cp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Chronic Pancreatitis (CP) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/chronic-pancreatitis-cp-global-market-report

Browse Through More Reports Similar to the Global Chronic Pancreatitis (CP) Market 2026, By The Business Research Company

Invasive Ductal Carcinoma Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/invasive-ductal-carcinoma-therapeutics-global-market-report

Pancreatic Cancer Diagnostic Market Report 2026

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-diagnostic-global-market-report

Exocrine Pancreatic Insufficiency Market Report 2026

https://www.thebusinessresearchcompany.com/report/exocrine-pancreatic-insufficiency-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795